Isolyte S pH 7.4
Active substance: SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, POTASSIUM PHOSPHATE, MONOBASIC
INJECTION, SOLUTION · SODIUM CHLORIDE .53 g/100mL, SODIUM GLUCONATE .5 g/100mL, SODIUM ACETATE .37 g/100mL, POTASSIUM CHLORIDE .037 g/100mL, MAGNESIUM CHLORIDE .03 g/100mL, SODIUM PHOSPHATE, DIBASIC .012 g/100mL, POTASSIUM PHOSPHATE, MONOBASIC .00082 g/100mL
United StatesActive
Marketing holder: B. Braun Medical Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM CHLORIDE · .53 g/100mL
- SODIUM GLUCONATE · .5 g/100mL
- SODIUM ACETATE · .37 g/100mL
- POTASSIUM CHLORIDE · .037 g/100mL
- MAGNESIUM CHLORIDE · .03 g/100mL
- SODIUM PHOSPHATE, DIBASIC · .012 g/100mL
- POTASSIUM PHOSPHATE, MONOBASIC · .00082 g/100mL
Registration
- Registration number
- 0264-7707
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 0264-7707 · Verified 2026-10-09 · open in source